Mark Anderson
The advent of start-ups in the field of biotechnology has witnessed promising growth, notably in England. Founded in 2020 or later, the following companies have been transforming the industry through cutting edge technologies and ground-breaking solutions. From the creation of animal fat without animals to the use of AI in drug discovery, these start-ups are setting impressive benchmarks.
Headquartered in the UK, these biotechnological start-ups have made substantial advancements in areas such as medical diagnostics, drug development, and therapeutic practices. Their innovative strategies have the potential to redefine the future of biotechnology and related sectors. Let’s take a closer look at these companies ushering in this new era of scientific endeavour and commercial innovation:
In no particular order, here is a selection of startups that are catalysts for change.
Hoxton Farms
Co-founded by Ed Steele and Max Jamilly, Hoxton Farms is a biotech company that specialises in growing real animal fat without animals. Based in London, Hoxton Farms merges cell biology and mathematical modelling to produce cultivated fat for the alternative meat industry. Follow them on @hoxtonfarms or via LinkedIn.
Dunad Therapeutics
Founded by Diana Kraskouskaya and Patrick T. Gunning, Dunad Therapeutics aims to revolutionise the biopharmaceutical industry. This London-based company focuses on creating targeted protein degradation therapies.
Bactobio
Daniel Blicher Holst Hansen founded Bactobio with an aim to solve the antibiotic resistance crisis. Using cutting-edge technologies, including synthetic biology and machine learning, Bactobio identifies novel microbes for medical and industrial applications. Connect with them on @bactobio or LinkedIn.
Purespring Therapeutics
Founded by Moin Saleem, Purespring Therapeutics is a gene therapy company focusing on kidney health. Get the latest updates on Twitter @PURESPRINGTX or find more information on LinkedIn.
Duke Street Bio
Duke Street Bio is a biotech start-up established in 2020 in London. They work on creating improved treatments for cancer patients. Learn more about their progress on LinkedIn.
Kuano
Co-founded by David Wright, Jarryl D’Oyley, Parminder Ruprah, and Vid Stojevic, Kuano offers quantum and AI solutions for drug discovery and design. Their innovation is aimed at speeding up the development of effective drug candidates. Follow them on @QuantumKuano or via LinkedIn.
Complement Therapeutics
With its headquarters in London, Complement Therapeutics is a preclinical stage company that develops precision medicine diagnostic platforms. The company is centred on gathering insights about patients’ complement-activation profiles. Find out more on their LinkedIn profile.
ProtonDx
ProtonDx is a diagnostic platform that offers molecular testing services. Co-founded by Jesus Rodriguez Manzano, Nicolas Moser, and Pantelis Georgiou, ProtonDx ensures quick, sensitive, and specific responses to identify multiple pathogens. Connect with them on LinkedIn.
Digistain
Founded by Christopher Phillips and Hemmel Amrania, Digistain leverages infrared scanning to identify breast cancer patients fit for chemotherapy. Keep up with their progress on LinkedIn.
AccuStem Sciences
AccuStem Sciences is a life sciences start-up committed to improving cancer patient outcomes. Based in London, their approach and research is dedicated to cancer treatment advancements.
Inspira Pharmaceuticals
Inspira Pharmaceuticals, founded by Nick Woolf and Rory McGoldrick, focuses on the treatment of respiratory diseases. Based in London, they apply advanced technology to develop therapies and preventive drugs. Follow them on Twitter at @Inspira_pharma or connect with them via LinkedIn.
